29 July, 2024 in Investor Relations, Videos Discover Nexalin’s Neurostimulation Device Targeting Mental Health Disorders
18 July, 2024 in Investor Relations Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
01 July, 2024 in Investor Relations Nexalin Technology Announces Closing of $5.2 Million Public Offering
